LONG-TERM EFFICACY RESULTS OF EORTC GU GROUP STUDY 30911 COMPARING EPIRUBICIN, BACILLUS CALMETTE- GUERIN (BCG), AND BCG PLUS ISONIAZID IN PATIENTS WITH INTERMEDIATE AND HIGH RISK STAGE Ta T1 BLADDER CARCINOMA

Term Efficacy

Re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al. Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. Eur Urol 2010;57:766–73

European Urology ◽

10.1016/j.eururo.2010.02.037 ◽

2010 ◽

Vol 57 (6) ◽

pp. e57

Author(s):

Tommaso Cai ◽

Lorenzo Giuseppe Luciani ◽

Gianni Malossini

Keyword(s):

High Risk ◽

Urothelial Carcinoma ◽

Phase 3 ◽

Term Efficacy ◽

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

European Urology ◽

10.1016/j.eururo.2009.12.024 ◽

2010 ◽

Vol 57 (5) ◽

pp. 766-773 ◽

Cited By ~ 225

Author(s):

Richard J. Sylvester ◽

Maurizio A. Brausi ◽

Wim J. Kirkels ◽

Wolfgang Hoeltl ◽

Fernando Calais Da Silva ◽

...

Keyword(s):

High Risk ◽

Urothelial Carcinoma ◽

Phase 3 ◽

Term Efficacy ◽

Long-term efficacy results of EORTC Genito-Urinary Group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder

International braz j urol ◽

10.1590/s1677-55382010000400024 ◽

2010 ◽

Vol 36 (4) ◽

pp. 504-517

Author(s):

Andreas Bohle

Keyword(s):

High Risk ◽

Urothelial Carcinoma ◽

Phase 3 ◽

Term Efficacy ◽

Reply to Tomasso Cai, Lorenzo Giuseppe Luciani and Gianni Malossini’s Letter to the Editor re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al. Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. Eur Urol 2010;57:766–73

European Urology ◽

10.1016/j.eururo.2010.02.038 ◽

2010 ◽

Vol 57 (6) ◽

pp. e58-e59

Author(s):

Richard J. Sylvester ◽

Maurizio A. Brausi ◽

Ziya Kirkali ◽

Theo M. de Reijke

Keyword(s):

High Risk ◽

Urothelial Carcinoma ◽

Phase 3 ◽

Term Efficacy ◽

Letter To The Editor ◽

Re: Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

European Urology ◽

10.1016/j.eururo.2011.03.040 ◽

2011 ◽

Vol 59 (6) ◽

pp. 1065

Author(s):

Donald L. Lamm

Keyword(s):

High Risk ◽

Urothelial Carcinoma ◽

Phase 3 ◽

Term Efficacy ◽

Re: Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin Plus Isoniazid in Patients With Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

The Journal of Urology ◽

10.1016/j.juro.2011.05.038 ◽

2011 ◽

Vol 186 (3) ◽

pp. 840-840

Author(s):

David P. Wood

Keyword(s):

High Risk ◽

Urothelial Carcinoma ◽

Phase 3 ◽

Term Efficacy ◽

Long-term efficacy of immunization against hepatitis B virus in infants at high-risk analyzed by polymerase chain reaction

Vaccine ◽

10.1016/s0264-410x(99)00320-5 ◽

1999 ◽

Vol 18 (7-8) ◽

pp. 581-587 ◽

Cited By ~ 21

Author(s):

Hiroyuki Kato ◽

Keisuke Nakata ◽

Keisuke Hamasaki ◽

Daisaku Hida ◽

Hiroki Ishikawa ◽

...

Keyword(s):

Polymerase Chain Reaction ◽

Hepatitis B Virus ◽

High Risk ◽

Hepatitis B ◽

Chain Reaction ◽

Term Efficacy ◽

B Virus ◽

Polymerase Chain

LONG-TERM FOLLOW-UP OF A RANDOMISED TRIAL COMPARING SEQUENTIAL BACILLUS CALMETTE-GUÈRIN AND ELECTROMOTIVE MITOMYCIN-C WITH BACILLUS CALMETTE GUÈRIN ALONE IN HIGH-RISK SUPERFICIAL BLADDER CANCER

European Urology Supplements ◽

10.1016/s1569-9056(06)60679-9 ◽

2006 ◽

Vol 5 (2) ◽

pp. 191 ◽

Cited By ~ 1

Author(s):

S.M. Di Stasi ◽

A. Giannantoni ◽

A. Giurioli ◽

G. Vespasiani ◽

G. Zampa ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Superficial Bladder Cancer ◽

Randomised Trial ◽

Long Term Follow Up

Long-Term Intravesical Adjuvant Chemotherapy Further Reduces Recurrence Rate Compared with Short-Term Intravesical Chemotherapy and Short-Term Therapy with Bacillus Calmette-Guérin (BCG) in Patients with Non–Muscle-Invasive Bladder Carcinoma

European Urology ◽

10.1016/j.eururo.2007.02.063 ◽

2007 ◽

Vol 52 (4) ◽

pp. 1123-1130 ◽

Cited By ~ 82

Author(s):

Martin G. Friedrich ◽

Uwe Pichlmeier ◽

Hartwig Schwaibold ◽

Stefan Conrad ◽

Hartwig Huland

Keyword(s):

Adjuvant Chemotherapy ◽

Recurrence Rate ◽

Bladder Carcinoma ◽

Intravesical Chemotherapy ◽

Term Therapy ◽

Short Term ◽

Short Term Therapy ◽

Muscle Invasive

Long-term Efficacy and Tolerability of Perospirone for Young Help-seeking People at Clinical High Risk: a Preliminary Open Trial

Clinical Psychopharmacology and Neuroscience ◽

10.9758/cpn.2013.11.3.132 ◽

2013 ◽

Vol 11 (3) ◽

pp. 132-136 ◽

Cited By ~ 8

Author(s):

Naohisa Tsujino ◽

Takahiro Nemoto ◽

Keiko Morita ◽

Naoyuki Katagiri ◽

Shinya Ito ◽

...

Keyword(s):

High Risk ◽

Help Seeking ◽

Open Trial ◽

Clinical High Risk ◽

Term Efficacy